Literature DB >> 11838568

Upper respiratory tract infections.

N Jain1, R Lodha, S K Kabra.   

Abstract

Acute respiratory infections accounts for 20-40% of outpatient and 12-35% of inpatient attendance in a general hospital. Upper respiratory tract infections including nasopharyngitis, pharyngitis, tonsillitis and otitis media constitute 87.5% of the total episodes of respiratory infections. The vast majority of acute upper respiratory tract infections are caused by viruses. Common cold is caused by viruses in most circumstances and does not require antimicrobial agent unless it is complicated by acute otitis media with effusion, tonsillitis, sinusitis, and lower respiratory tract infection. Sinusitis is commonly associated with common cold. Most instances of rhinosinusitis are viral and therefore, resolve spontaneously without antimicrobial therapy. The most common bacterial agents causing sinusitis are S. pneumoniae, H. influenzae, M. catarrhalis, S. aureus and S. pyogenes. Amoxycillin is antibacterial of choice. The alternative drugs are cefaclor or cephalexin. The latter becomes first line if sinusitis is recurrent or chronic. Acute pharyngitis is commonly caused by viruses and does not need antibiotics. About 15% of the episodes may be due to Group A beta hemolytic streptococcus (GABS). Early initiation of antibiotics in pharyngitis due to GABS can prevent complications such as acute rheumatic fever. The drug of choice is penicillin for 10-14 days. The alternative medications include oral cephalosporins (cefaclor, cephalexin), amoxicillin or macrolides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11838568      PMCID: PMC7091368          DOI: 10.1007/bf02722930

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  18 in total

1.  Acute respiratory diseases of viral etiology. VII. Present concepts of the common cold.

Authors:  G G JACKSON; H F DOWLING; R L MULDOON
Journal:  Am J Public Health Nations Health       Date:  1962-06

2.  Rheumatic heart disease; a challenge.

Authors:  C H RAMMELKAMP
Journal:  Circulation       Date:  1958-05       Impact factor: 29.690

Review 3.  Sinusitis in children.

Authors:  E R Wald
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

4.  Respiratory viral infection in childhood. A survey in general practice, Roehampton 1967-1972.

Authors:  M E Horn; E Brain; I Gregg; S J Yealland; J M Inglis
Journal:  J Hyg (Lond)       Date:  1975-04

5.  Acute respiratory infection in children: a survey in the rural community.

Authors:  M P Tambe; C Shivaram; Y Chandrashekhar
Journal:  Indian J Med Sci       Date:  1999-06

Review 6.  Childhood sinusitis: pathophysiology, diagnosis and treatment.

Authors:  G S Giebink
Journal:  Pediatr Infect Dis J       Date:  1994-01       Impact factor: 2.129

Review 7.  Judicious use of antibiotics for common pediatric respiratory infections.

Authors:  R F Jacobs
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

8.  Bacteriology and treatment of purulent nasopharyngitis: a double blind, placebo-controlled evaluation.

Authors:  J K Todd; N Todd; J Damato; W A Todd
Journal:  Pediatr Infect Dis       Date:  1984 May-Jun

9.  A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity.

Authors:  M E Pichichero; P A Margolis
Journal:  Pediatr Infect Dis J       Date:  1991-04       Impact factor: 2.129

Review 10.  Resistance among problem respiratory pathogens in pediatrics.

Authors:  G V Doern
Journal:  Pediatr Infect Dis J       Date:  1995-05       Impact factor: 2.129

View more
  24 in total

Review 1.  Effects of yeast β-glucans for the prevention and treatment of upper respiratory tract infection in healthy subjects: a systematic review and meta-analysis.

Authors:  Kunxia Zhong; Zhiqin Liu; Yao Lu; Xi Xu
Journal:  Eur J Nutr       Date:  2021-04-26       Impact factor: 5.614

2.  Pediatric Respiratory Virus Infections During the COVID-19 Pandemic in a Region Without Active Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Circulation.

Authors:  Sosuke Kakee; Yoichi Mino; Keisuke Okuno; Daisuke Kawaba; Atsushi Maejima; Noriyuki Namba
Journal:  Yonago Acta Med       Date:  2022-08-29       Impact factor: 1.371

3.  Identifying socio-ecological drivers of common cold in Bhutan: a national surveillance data analysis.

Authors:  Tsheten Tsheten; Kinley Penjor; Chachu Tshering; Archie C A Clements; Darren J Gray; Kinley Wangdi
Journal:  Sci Rep       Date:  2022-07-09       Impact factor: 4.996

4.  Difficulties in species identification within the genus Haemophilus - A pilot study addressing a significant problem for routine diagnostics.

Authors:  H Frickmann; A Podbielski; A Essig; N G Schwarz; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-05-21

5.  Azithromycin in acute bacterial upper respiratory tract infections: an Indian non-interventional study.

Authors:  Shaantanu Donde; Anupam Mishra; Puja Kochhar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-01-07

6.  Inclusion of Cephalexin in COVID-19 Treatment Combinations May Prevent Lung Involvement in Mild Infections: A Case Report with Pharmacological Genomics Perspective.

Authors:  Amir Khodavirdipour
Journal:  Glob Med Genet       Date:  2021-03-22

7.  Drug utilization pattern of antibacterials used in ear, nose and throat outpatient and inpatient departments of a university hospital at New Delhi, India.

Authors:  M R Ain; N Shahzad; M Aqil; M S Alam; R Khanam
Journal:  J Pharm Bioallied Sci       Date:  2010-01

8.  Antimicrobial and Antibiofilm Activities of Weissella cibaria against Pathogens of Upper Respiratory Tract Infections.

Authors:  Ji-Eun Yeu; Hyeon-Gyu Lee; Geun-Yeong Park; Jisun Lee; Mi-Sun Kang
Journal:  Microorganisms       Date:  2021-05-30

9.  Chinese medicine injection shuanghuanglian for treatment of acute upper respiratory tract infection: a systematic review of randomized controlled trials.

Authors:  Hongwei Zhang; Qin Chen; Weiwei Zhou; Shi Gao; Huiguang Lin; Shuifen Ye; Yihui Xu; Jing Cai
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-30       Impact factor: 2.629

10.  Coal Mine Air Pollution and Number of Children Hospitalizations because of Respiratory Tract Infection: A Time Series Analysis.

Authors:  Yonglin Liu; Juan Liu; Fenglian Chen; Shamsi Bilal Haider; Qiang Wang; Fuyong Jiao; Yanmei Qiao; Yanhua Shi
Journal:  J Environ Public Health       Date:  2015-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.